Cesarone C F, Scarabelli L, Giannoni P, Orunesu M
Institute of General Physiology, University of Genoa, Italy.
Biochem Biophys Res Commun. 1994 Sep 30;203(3):1548-53. doi: 10.1006/bbrc.1994.2362.
The in vivo effect of the thyroidal state on poly(ADP-ribose) polymerase activity was investigated in eu- and hypothyroid rats after treatment with L-triiodothyronine. Untreated hypothyroids showed an increased basal rate of the enzyme. The treatment of both eu- and hypothyroid rats with L-triiodothyronine induced a prompt drop of the endogenous activity not due to a reduction of the catalytic protein. This decrease well evident 1 h after treatment was transient, returning to controls values within 8 h. In isolated liver nuclei from euthyroids the in vitro exposure to increasing L-triiodothyronine concentrations from 10(-18) to 10(-6) M resulted in a progressive inhibition of the enzyme. This loss in activity was not derived from a reduction of the total level of the catalytic protein. The pretreatment with the antagonist amiodarone suppressed the hormone effect, suggesting that nuclear receptors could mediate poly(ADP-ribose) polymerase activity.
在用L-三碘甲状腺原氨酸治疗的正常甲状腺和甲状腺功能减退大鼠中,研究了甲状腺状态对聚(ADP-核糖)聚合酶活性的体内影响。未经治疗的甲状腺功能减退大鼠显示该酶的基础速率增加。用L-三碘甲状腺原氨酸治疗正常甲状腺和甲状腺功能减退大鼠均导致内源性活性迅速下降,这并非由于催化蛋白减少所致。治疗后1小时明显出现的这种下降是短暂的,8小时内恢复到对照值。在来自正常甲状腺大鼠的分离肝细胞核中,体外暴露于浓度从10(-18)至10(-6)M不断增加的L-三碘甲状腺原氨酸中,导致该酶逐渐受到抑制。这种活性丧失并非源于催化蛋白总水平的降低。用拮抗剂胺碘酮预处理可抑制激素效应,表明核受体可能介导聚(ADP-核糖)聚合酶活性。